Bepridil up‐regulates cardiac Na+channels as a long‐term effect by blunting proteasome signals through inhibition of calmodulin activity
Authors:
Open Access
- 21 May 2009
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 157 (3) , 404-414
Abstract
Background and purpose: Bepridil is an anti‐arrhythmic agent with anti‐electrical remodelling effects that target many cardiac ion channels, including the voltage‐gated Na+channel. However, long‐term effects of bepridil on the Na+channel remain unclear. We explored the long‐term effect of bepridil on the Na+channel in isolated neonatal rat cardiomyocytes and in a heterologous expression system of human Nav1.5 channel.Experimental approach: Na+currents were recorded by whole‐cell voltage‐clamp technique. Na+channel message and protein were evaluated by real‐time RT‐PCR and Western blot analysis.Key results: Treatment of cardiomyocytes with 10 µmol·L−1bepridil for 24 h augmented Na+channel current (INa) in a dose‐ and time‐dependent manner. This long‐term effect of bepridil was mimicked or masked by application of W‐7, a calmodulin inhibitor, but not KN93 [2‐[N‐(2‐hydroxyethyl)‐N‐(4‐methoxy benzenesulphonyl)]‐amino‐N‐(4‐chlorocinnamyl)‐N‐methylbenzylamine], a Ca2+/calmodulin‐dependent kinase inhibitor. During inhibition of protein synthesis by cycloheximide, theINaincrease due to bepridil was larger than the increase without cycloheximide. Bepridil and W‐7 significantly slowed the time course of Nav1.5 protein degradation in neonatal cardiomyocytes, although the mRNA levels of Nav1.5 were not modified. Bepridil and W‐7 did not increaseINaany further in the presence of the proteasome inhibitor MG132 [N‐[(phenylmethoxy)carbonyl]‐L‐leucyl‐N‐[(1S)‐1‐formyl‐3‐methylbutyl]‐L‐leucinamide]. Bepridil, W‐7 and MG132 but not KN93 significantly decreased 20S proteasome activity in a concentration‐dependent manner.Conclusions and implications: We conclude that long‐term exposure of cardiomyocytes to bepridil at therapeutic concentrations inhibits calmodulin action, which decreased degradation of the Nav1.5 α‐subunit, which in turn increased Na+current.Keywords
This publication has 41 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Short- and Long-Term Amiodarone Treatments Regulate Cav3.2 Low-Voltage-Activated T-type Ca2+ Channel through Distinct MechanismsMolecular Pharmacology, 2006
- Conversion and Maintenance of Sinus Rhythm by Bepridil in Patients With Persistent Atrial FibrillationCirculation Journal, 2005
- The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heartThe Journal of Physiology, 2001
- Bepridil differentially inhibits two delayed rectifier K+ currents, IKr and IKs, in guinea‐pig ventricular myocytesBritish Journal of Pharmacology, 1999
- BepridilDrugs, 1992
- Effects of bepridil on cardiac electrophysiologic propertiesThe American Journal of Cardiology, 1992
- Interactions of calmodulin antagonists with calcium antagonists binding sitesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Pharmacokinetics and metabolism of bepridilThe American Journal of Cardiology, 1985
- Bepridil for recurrent sustained ventricular tachycardias: Assessment using electrophysiologic testingThe American Journal of Cardiology, 1984